CASE DISCUSSION
Vasopressor Management in Septic Shock: Overview & Approach
Presented from India by Dr. Pooja WadwaViews
13,252
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Vasopressors are essential in managing septic shock by maintaining adequate perfusion pressure and organ perfusion. Initial management involves prompt recognition of septic shock and fluid resuscitation. Norepinephrine is typically the first-line vasopressor, acting through alpha-adrenergic...
Case Summary
- In the 4th century BC, Hippocrates suggested fever as a major symptom. Louis Pasteur discovered bacteria in the blood in 1979-80. In 1991, the Society of Critical Care Medicine defined SIRS. Diagnostic criteria were expanded in 2001, and guidelines were laid down in 2016.
Speaker Profile
Dr. Pooja Wadwa
Alumni- Royal Melbourne HospitalAdditional Director, Critical Care Medicine, ECMO Specialist, FMRI, Gurgaon
Clinical Director, Critical Care Medicine & ECMO Specialist, Marengo Asia Hospitals, Gurgaon (formerly Additional Director, FMRI)
Dr. Pooja Wadwa is a highly experienced critical care specialist and ECMO expert with over 12 years in the field. She completed her MBBS (2002) from Indira Gandhi Medical College, Nagpur, and MD (Internal Medicine, 2006) from Dayanand Medical College & Hospital, Ludhiana. She also underwent an ICU Observership at Royal Melbourne Hospital, Australia, and completed her IDCCM (Indian Diploma in Critical Care Medicine) from Indraprastha Apollo Hospital, New Delhi. She was previously the Additional Director of Critical Care Medicine and an ECMO Specialist at Fortis Memorial Research Institute (FMRI), Gurgaon, where she was instrumental in developing ECMO protocols and raising critical care standards. She has recently joined Marengo Asia Hospitals, Gurugram, as Clinical Director of Critical Care Medicine, focusing on digital ICU technologies, ECMO expansion, and advanced critical care delivery.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.